Nachrichten zur Inovio Pharmaceuticals Inc. Aktie

INO FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Inovio Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action – INO

NEW YORK, April 05, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

Inovio Pharmaceuticals stock tumbles on dilutive offering

Inovio Pharmaceuticals stock tumbles on dilutive offering…

Inovio Pharmaceuticals, Inc. (INO) Q4 2025 Earnings Call Transcript

…

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Inovio Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – INO

NEW YORK, Feb. 28, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

Holzer & Holzer, LLC Reminds INO Investors of the April 7, 2026 Lead Plaintiff Deadline in the Inovio Pharmaceuticals, Inc. Securities Class Action

ATLANTA, Feb. 24, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Inovio Pharmaceuticals,…

ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INO

NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

ROSEN, LEADING INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INO

NEW YORK, Feb. 16, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Inovio Pharmaceuticals, Inc. (INO)

NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action…

Inovio Pharmaceuticals: Speculative Buy Thesis Hinges On INO-3107

…

Inovio Pharmaceuticals (INO) Expected to Beat Earnings Estimates: Should You Buy?

Inovio (INO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…

Inovio Pharmaceuticals stock plunges after announcing public offering By Investing.com

Inovio Pharmaceuticals stock plunges after announcing public offering…

Inovio Pharmaceuticals (INO) Reports Q1 Loss, Tops Revenue Estimates

Inovio (INO) delivered earnings and revenue surprises of 31.08% and 30%, respectively, for the quarter ended March 2025. Do the…

Bet on These 5 Top-Ranked Stocks With Rising P/E

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Carvana, Context Therapeutics Inc,…

Inovio Pharmaceuticals, Inc. 2024 Q4 - Results - Earnings Call Presentation

…

Inovio Pharmaceuticals, Inc. (INO) Q4 2024 Earnings Call Transcript

…

Inovio Pharmaceuticals: The Dangerous Allure Of A Falling Knife

…

Inovio Pharmaceuticals (INO) Q3 2024 Earnings Call Transcript

INO earnings call for the period ending September 30, 2024.…

Inovio Pharmaceuticals, Inc. (INO) Q3 2024 Earnings Call Transcript

…

Inovio Pharmaceuticals, Inc. 2024 Q3 - Results - Earnings Call Presentation

…

Inovio Pharmaceuticals, Inc. (INO) Q2 2024 Earnings Call Transcript

…

Inovio Pharmaceuticals (INO) Q2 2024 Earnings Call Transcript

INO earnings call for the period ending June 30, 2024.…

Inovio Pharmaceuticals: Upcoming BLA Is Critical

…

Global Bipolar Disorder Market Size To Exceed USD 6.47 Billion By 2033 | CAGR Of 1.98%

The Global Bipolar Disorder Market Size was Valued at USD 5.32 Billion in 2023, the Worldwide Bipolar Disorder Market Size…

Better Buy: Inovio Pharmaceuticals vs. Novavax

…

Better Buy: Inovio Pharmaceuticals vs. Novavax

Both biotechs have been struggling for a while, but there might be some hope for them.…

Inovio Pharmaceuticals, Inc. (INO) H.C. Wainwright 2nd Annual BioConnect Investor Conference (Transcript)

…

Global Oral Transmucosal Drugs Market Size To Exceed USD 62.3 Billion By 2033 | CAGR Of 6.5%

The Global Oral Transmucosal Drugs Market Size was Valued at USD 33.2 Billion in 2023 and the Worldwide Oral Transmucosal…

Inovio Pharmaceuticals, Inc. (INO) Presents at 2024 RBC Capital Markets Global Healthcare Conference (Transcript)

…

Inovio Pharmaceuticals, Inc. (INO) The Citizens JMP Life Sciences Conference (Transcript)

…

Oppenheimer maintains price target on Inovio Pharmaceuticals stock By Investing.com

Oppenheimer maintains price target on Inovio Pharmaceuticals stock…

Inovio Pharmaceuticals (INO) Q1 2024 Earnings Call Transcript

INO earnings call for the period ending March 31, 2024.…

Inovio Pharmaceuticals, Inc. (INO) Q1 2024 Earnings Call Transcript

…

Inovio Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation

…

Ausblick: Inovio Pharmaceuticals öffnet die Bücher zum abgelaufenen Quartal

Inovio Pharmaceuticals wird am 13.05.2024 das Zahlenwerk zum am 31.03.2024 abgelaufenen Jahresviertel vorstellen.In Sachen EPS gehen 5 Analysten von einem…

Inovio Pharmaceuticals: Neutral On INO-3107 Amidst Stock Dilution And High Valuation

…

Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript

INO earnings call for the period ending December 31, 2023.…

Inovio Pharmaceuticals, Inc. (INO) Q4 2023 Earnings Call Transcript

…

dpa-AFX ProFeed